1. Project BioShield Act of 2004, S 15, 108th Congress, (2004). https://www.congress.gov/bill/108th-congress/senate-bill/15. Accessed 14 May 2021.
2. U.S Food & Drug Administration. MCM Emergency Use Authorities. U.S Food & Drug Administration; 2021. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/mcm-emergency-use-authorities. Accessed 14 May 2021.
3. U.S Food & Drug Administration. Guidance Document: Emergency Use Authorization of Medical Products and Related Authorities. U.S Food & Drug Administration; 2017. https://www.fda.gov/media/97321/download. Accessed 21 July 2021.
4. U.S Food & Drug Administration. Emergency Use Authorization—Archived Information. U.S Food & Drug Administration; 2021. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization-archived-information. Accessed 14 May 2021.
5. Expanding Access to Investigational Therapies for HIV Infection and AIDS. National Academies Press; 1991. p. 1778. https://doi.org/10.17226/1778